FPN || FDA & CDC

FDA approves Viberzi and Xifaxan for IBS

Posted on: 28/05/2015 - 18:42

The Food and Drug Administration has approved Viberzi (eluxadoline) and Xifaxan (rifaximin) to treat irritable bowel syndrome with diarrhea (IBS-D) in adults, the agency announced May 27. Viberzi is...

Field of Interest: Gastroentero...

Type: News Item

CDC: LARC should be preferred contraceptive method for sexually active teens

Posted on: 07/04/2015 - 20:18

Despite birth rates among American teenagers continuing to decrease in recent years, not enough sexually active teens know of and use LARC, which the ... More »

Field of Interest: Pulmonology

Type: News Item

United States experiencing drug-resistant shigellosis outbreak

Posted on: 02/04/2015 - 18:00

The United States is currently experiencing an outbreak of shigellosis caused by a strain of the Shigella sonnei bacteria that is resistant to ciprofl... More »

Field of Interest: Gastroentero...

Type: News Item

CDC: Cancer incidence and survival improve; racial disparities persist

Posted on: 12/03/2015 - 17:00

Numerous states have achieved Healthy People 2020 goals for colorectal and cervical cancer incidence, and the proportion of persons with cancer who su... More »

Field of Interest: Oncology

Type: News Item

FDA panel backs injectable treatment for chin fat

Posted on: 09/03/2015 - 21:03

SILVER SPRING, MD – A less-invasive alternative to liposuction and other cosmetic treatments for submental fat will likely become available in the U... More »

Field of Interest: Dermatology

Type: News Item

ACIP votes on incorporating 9-valent HPV vaccine into recommendations

Posted on: 27/02/2015 - 16:17

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to support proposed recommendations for use of t... More »

Field of Interest: Pulmonology

Type: News Item

FDA allows marketing of vaginally inserted device for fecal incontinence

Posted on: 13/02/2015 - 18:32

A vaginally inserted device that uses a balloon inflated by the patient to occlude the rectum has been cleared for marketing as a treatment for fecal ... More »

Field of Interest: Gastroentero...

Type: News Item

FDA allows marketing of vaginally inserted device for fecal incontinence

Posted on: 13/02/2015 - 18:32

A vaginally inserted device that uses a balloon inflated by the patient to occlude the rectum has been cleared for marketing as a treatment for fecal ... More »

Field of Interest: Pulmonology

Type: News Item

Lenvima gets the FDA’s nod for differentiated thyroid cancer

Posted on: 13/02/2015 - 17:23

The Food and Drug Administration has approved the kinase inhibitor lenvatinib (Lenvima) for the treatment of differentiated thyroid cancer, the agency... More »

Field of Interest: Oncology

Type: News Item

Dermal filler approved for treating acne scars

Posted on: 09/02/2015 - 19:07

A collagen dermal filler already on the market has been approved for improving the appearance of acne scars in people aged 21 years and older. The f... More »

Field of Interest: Dermatology

Type: News Item

FDA approves Viberzi and Xifaxan for IBS

CDC: LARC should be preferred contraceptive method for sexually active teens

United States experiencing drug-resistant shigellosis outbreak

CDC: Cancer incidence and survival improve; racial disparities persist

FDA panel backs injectable treatment for chin fat

ACIP votes on incorporating 9-valent HPV vaccine into recommendations

FDA allows marketing of vaginally inserted device for fecal incontinence

FDA allows marketing of vaginally inserted device for fecal incontinence

Lenvima gets the FDA’s nod for differentiated thyroid cancer

Dermal filler approved for treating acne scars

Newsletters

Latest Newsletters

You are here

FPN || FDA & CDC

Newsletters

Latest Newsletters